Matthew Peter Kent

I am excited by the use of new technologies to answer complex questions in Genomics. Over the last 20 years leaps in technology have transformed our ability to reconstruct complex genomes, detect genetic variation, and annotate genomes with functional information and establish links between DNA and biology. Today, I am especially interested in long-read nanopore sequencing, high-throughput genotyping, functional genomic assays and CRISPR for establishing links between gene and function. However molecular genomic technologies are highly dynamic and the instrumentation and applications are constantly being refined and improved making it exciting to watch for the “next big thing”. Among others, some projects I am currently involved with include characterizing structural variants in cattle and pigs (CAUSATIVE), identifying mechanisms for sealice resistance (LiceRESIST), replacing live animal testing with in vitro models (PetriFish).

For more information, please visit our groups webpage: www.cigene.no